Who is affected by Alzheimer's disease

Citations

1. Martin S (2003). Canadians' awareness of Alzheimer's disease lacking. Canadian Medical Association Journal, 168(8): 1038.

2. Getsios D, et al. (2001). Assessment of health economics in Alzheimer's disease (AHEAD): Galantamine treatment in Canada. Neurology, 57: 972–978.

Author:	Douglas Dana Sabra L. Katz-Wise Ralph Poore	Last Updated: January 26, 2007
Medical Review:	Adam Husney, MD - Family Medicine Andrew Swan, MD, CCFP, FCFP - Family Medicine Peter J. Whitehouse, MD - Neurology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.